Gut bacteria vs. weight loss shot: Head-to-Head trial begins
NCT ID NCT06989177
Summary
This study aims to see if a specific probiotic (LC-19) can help with weight loss and improve metabolism as effectively as the medication semaglutide. It will involve 140 adults, most of whom are overweight or obese, who will follow a diet and lifestyle plan while also taking either the probiotic, the medication, or a placebo for 12 weeks. Researchers will closely track weight changes, body measurements, blood sugar, and other health markers to compare the two approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences
RECRUITINGHangzhou, Zhejiang, 310024, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.